Adjuvant chemotherapy after complete resection in non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1048-1054

  Wada, H ^a   Hitomi, S ^a   Teramatsu, T ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; UFT; VINDESINE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TREATMENT OUTCOME;

EID: 0029915893     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1048     Document Type: Article

References (21)

1. Watanabe Y, Shimizu J, Oda M, et al: Proposals regarding some deficincies in the new international staging system for non-small cell lung cancer. Jpn J Clin Oncol 21:160-168, 1991
2. Fujii S, Kitano S, Ikenaka K, et al: Studies on coadministration of uracil or cytosine on antitumor activity of FT-207 or 5-FU derivatives. Jpn J Cancer Chemother 6:377-384, 1979
3. Ansfield FJ, Kallas GJ, Singson JP: Phase I-II studies of oral tegafur (Ftorafur). J Clin Oncol 1:107-110, 1983
4. Fujii S, Ikenaka M, Fukushima M, et al: Effect of coadministration of uracil or cytosine on the antitumor activity of clinical doses of 1-(2-tetrahydro-furyl)-5-fluorouracil and level of 5-fluorouracil and level of 5-fluorouracil in rondents. Gann 70:209-214, 1979
5. Ota K, Taguchi T, Kimura K: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22:333-338, 1988
6. Yamada Y, Toko T, Miyauchi S, et al: Effect of UFT on immune responses in mice. Jpn J Cancer Chemother 7:2134-2140, 1980
7. Holmes EC, Bleehen NM, Chevalier TL, et al: Postoperative adjuvant treatments for non-small cell lung cancers: A consensus report. Lung Cancer 7:11-13, 1991
8. Holmes C, Gail M, Lung Cancer Study Group: Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 4:710-715, 1986
9. Feld R, Rubinstein L, Thomas PA, et al: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. J Natl Cancer Inst 85:299-306, 1993
10. Niiranen A, Niitamo-Korhonen S, Kouri M, et al: Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study. J Clin Oncol 10:1927-1932, 1992
11. Ohta M, Tsuchiya R, Shimoyama M, et al: Adjuvant chemotherapy for completely resected stage III non-small cell lung cancer. J Thorac Cardiovasc Surg 106:703-708, 1993
12. Stewart LA, Pignon JP, Arriagada R, et al: A meta-analysis using individual patient data from randomised clinical trials (RCTS) of chemotherapy (CT) in non-small cell lung cancer (NSCLC): (1) Survival in the surgical setting. Proc Am Soc Clin Oncol 13:336, 1994 (abstr 1117)
13. Shimizu N, Teramoto S, Hitomi S, et al: A randomized controlled postoperative adjuvant chemotherapy trial of MMC + Tegafur and MMC + UFT for adenocarcinoma of the lung-first study. Jpn J Lung Cancer 31:1011-1019, 1991
14. Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
15. Nakao S, Hasegawa H, Ishii T, et al: The effect of UFT on lymphocyte subsets and lymphocyte responce to PHA. Jpn J Cancer Chemother 14:3157-3159, 1987
16. Suemasu K, Nomoto C, Higashi Y: Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT. Jpn J Cancer Chemother 9:667-671, 1982
17. Namatame K, Sasaki E, Ko Y, et al: A double-blind comparison of FUra plasma concentration by oral (UFT) vs continuous intravenous infusion (5-FU). Jpn J Cancer Chemother 20:2417-2419, 1993
18. Pazer R, Lassere Y, Ajani JA, et al:. Phase II trial of uracil and tegafur plus oral luecovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol 12:2296-2300, 1994
19. Ichinose Y, Takanashi N, Yano T, et al: A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer. Cancer 75:2677-2680, 1995
20. Mitomi T, Tsuchiya S, Hiki Y, et al: A randomized controlled study on adjuvant chemotherapy with UFT in curatively resected colorectal cancer. Proc Am Soc Clin Oncol 12:225, 1993 (abstr 690)
21. Kubota Y, Hosaka M, Fukushima S, et al: Prophylactic oral UFT therapy for superficical bladder cancer. Cancer 71:1842-1845, 1993